previous compound ID: 1467 next compound
InChIKey: NGBFQHCMQULJNZ-UHFFFAOYSA-N
SMILES: CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"D Rotin" "J Liao" "SD Macknight" "DY Thomas" "GW Carlile" "B Kus" "J Goepp" "JW Hanrahan" "R Robert" "E Matthes"

chemical graph of compound 1467





CID is 41781
synonyms found at PubChem are:
Torasemide, TORSEMIDE, 56211-40-6, Demadex, Torasemida, Torasemidum, Luprac, Torasemidum [INN-Latin], Torasemida [INN-Spanish], Toradiur, Torsemide [USAN], Dilutol, Presoril, Torocard, Sutril, Torrem, Torem, Unat, JDL 464, Torasemide N, N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide, UNII-W31X2H97FB, Torsemide (USP), 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea, Demadex (TN), AC 4464, Luprac (TN), Torsemide (Demadex), CCRIS 6736, BM 02015, BM-02015, Torasemide (JAN/INN), AC4464, AC-4464, BRN 0498515, N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide, MLS001165687, CHEBI:9637, W31X2H97FB, JDL-464, Torasemide, Anhydrous, GJ-1090, KS-1123, PW-2132, NCGC00016879-01, SMR000466313, 1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea, 1-isopropyl-3-((4-(3-methylphenylamino)pyridine)-3-sulfonyl)urea, CAS-56211-40-6, DSSTox_CID_3690, DSSTox_RID_77149, DSSTox_GSID_23690, Q-201846, 4-[(3-methylphenyl)amino]-N-(propan-2-ylcarbamoyl)pyridine-3-sulfonamide, N-[(isopropylamino)carbonyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide, 3-Pyridinesulfonamide, N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-, 3-Pyridinesulfonamide, N-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-, n-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide, N-{[(1-methylethyl)amino]carbonyl}-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide, Torsemide [USAN:USP], Demadex, Torsemide, Torasemide [INN], PubChem18545, Spectrum_001776, AC1Q6UVM, Prestwick0_001030, Prestwick1_001030, Prestwick2_001030, Prestwick3_001030, Spectrum2_001142, Spectrum3_001832, Spectrum4_000290, Spectrum5_001699, D0J9XZ, CHEMBL1148, SCHEMBL41184, BSPBio_001219, BSPBio_003503, KBioGR_000820, KBioSS_002257, cid_41781, MLS000759418, MLS001195611, MLS001424121, MLS006010744, BIDD:GT0623, SPECTRUM1505211, SPBio_001063, SPBio_003080, AC1L26H7, BPBio1_001341, GTPL7312, ZINC5823, DTXSID2023690, BDBM64107, CTK8B3035, KBio2_002256, KBio2_004824, KBio2_007392, KBio3_003008, MolPort-002-885-870, NGBFQHCMQULJNZ-UHFFFAOYSA-N, HMS1571M21, HMS1922N05, HMS2051L21, HMS2098M21, HMS2234N14, HMS3373G20, HMS3393L21, HMS3715M21, ALBB-027267, BCP07286, HY-B0247, ZX-AN025776, Tox21_110662, AN-919, ANW-41652, BG0484, CCG-40257, CT0260, MFCD00866166, s1698, STL388026, Torsemide, >=98% (HPLC), solid, AKOS015894937, Tox21_110662_1, API0004454, CS-2227, DB00214, MCULE-2734924315, NC00238, VA11897, NCGC00016879-02, NCGC00016879-03, NCGC00016879-04, NCGC00016879-06, NCGC00016879-07, NCGC00095141-01, NCGC00095141-02, NCGC00095141-03, AC-18762, BM02.015, CC-35108, CPD000466313, SAM001246567, SC-13773, ACM1189375061, AB0006854, AB2000227, LS-131973, TL8003646, TR-019752, AB00514011, FT-0630689, R3923, D00382, AB00514011-09, AB00514011_10, AB00514011_11, 211T406, A830961, C-20564, SR-01000759362, I06-0056, SR-01000759362-5, BRD-K30480208-001-05-2, 1-isopropyl-3-[(4-m-toluidino-3-pyridyl) sulfonyl]urea, 1-isopropyl-3-[(4- m -toluidino-3-pyridyl) sulfonyl]urea, 1-isopropyl-3-[[4-(3-methylanilino)-3-pyridyl]sulfonyl]urea, Torsemide, United States Pharmacopeia (USP) Reference Standard, 1-[[4-(3-methylanilino)-3-pyridinyl]sulfonyl]-3-propan-2-ylurea, Torasemide anhydrous, European Pharmacopoeia (EP) Reference Standard, 1-[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl-3-propan-2-yl-urea, 1-{4-[(3-methylphenyl)amino]pyridine-3-sulfonyl}-3-(propan-2-yl)urea, N-(isopropylcarbamoyl)-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide, N-[(propan-2-yl)carbamoyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide, 3-pyridinesulfonamide,N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-, N-({4-[(3-methylphenyl)imino]-1,4-dihydropyridin-3-yl}sulfonyl)propane-2-carbamimidic acid, Torasemide for system suitability, European Pharmacopoeia (EP) Reference Standard, ZB000619